•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A01647 Summary:

BILL NOA01647
 
SAME ASSAME AS S02331
 
SPONSORRosenthal
 
COSPNSRDinowitz, Simon, Reyes, Steck, Gonzalez-Rojas, Burdick, Mamdani, Forrest, Hevesi, Cruz, Clark, Gallagher, Taylor, Weprin, Walker, Shrestha, Davila, Mitaynes, Bichotte Hermelyn, Epstein
 
MLTSPNSR
 
Amd §220.00, Pen L
 
Decriminalizes the possession of buprenorphine from certain crimes.
Go to top

A01647 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          1647
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 10, 2025
                                       ___________
 
        Introduced  by M. of A. ROSENTHAL, DINOWITZ, SIMON, REYES, STECK, GONZA-
          LEZ-ROJAS, BURDICK, MAMDANI, FORREST, HEVESI, CRUZ, CLARK,  GALLAGHER,
          TAYLOR, WEPRIN, WALKER, SHRESTHA, DAVILA, MITAYNES, BICHOTTE HERMELYN,
          EPSTEIN -- read once and referred to the Committee on Codes
 
        AN  ACT  to  amend  the  penal  law,  in relation to decriminalizing the
          possession of buprenorphine
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Subdivisions  5 and 8 of section 220.00 of the penal law,
     2  subdivision 5 as amended by chapter 92 of the laws of 2021 and  subdivi-
     3  sion  8 as amended by section 18 of part C of chapter 447 of the laws of
     4  2012, are amended to read as follows:
     5    5. "Controlled substance" means any substance listed  in  schedule  I,
     6  II,  III,  IV  or  V  of  section thirty-three hundred six of the public
     7  health law other than buprenorphine.
     8    8. "Narcotic preparation" means any  controlled  substance  listed  in
     9  schedule II(b-1), III(d) or III(e), other than buprenorphine.
    10    § 2. This act shall take effect on the first of November next succeed-
    11  ing the date on which it shall have become a law.
 
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD04454-01-5
Go to top